Maito, Nasra B.

HRN: 10-14-01  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2023
CEFUROXIME 750MG (VIAL)
01/09/2023
01/15/2023
IVT
750mg
Q8hrs
Uti
Waiting Final Action 
01/09/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/09/2023
01/16/2023
IV
270mg
Q8hours
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: